Alira Health

Alira Health and HTAi Collaborate to Develop Value Assessment Framework for RAS & Digital Health

Alira Health and HTAi Collaborate to Develop a Multi-Stakeholder Value Assessment Framework for Robotic-Assisted Surgery & Digital Health

Alira Health, a global healthcare consulting and technology firm with expertise in Health Technology Assessment (HTA) methodology, will coordinate the discussion and consensus of evidence-based guidance on HTA for Robotic-Assisted Surgery (RAS) and Digital Health Technologies.

This multi-stakeholder Value Assessment Framework will provide guidance on how to overcome challenges in determining the cost-effectiveness of robotic-assisted surgery from the perspectives of patients, physicians, and payers.

The framework, designed in collaboration with the HTAi Medical Device Interest Group, is technology and company agnostic. Key areas of guidance will include:

  • best practices in assessing the value of robotic-assisted surgery at both the national and hospital level;
  • how to support the implementation of RAS and Digital Health programs globally;
  • how to ensure the clinician and patient perspectives are included in the quantification of value.

The following areas of consensus will be sought from a panel of leading robotic-assisted surgeons, leading health economists, and policymakers:

  • Clinical Challenges
    • Evidence type and quality (RCT vs RWE)
    • Physician and patient-reported outcomes
    • Physician learning curve
  • Economic Challenges
    • Appropriate Time Horizon for evaluation
    • Challenges of a high upfront capital investment
    • Organizational impact on surgical procedures
  • Digital Challenges
    • Evaluation of an increasingly digitally-enabled RAS ecosystem
    • Overcoming the rapid evolution of digital solutions
News
Category:
Published on:
March 22, 2022
"The guidance will be aimed at HTA agencies globally and will allow them to better assess the value of robotic surgical and digital health systems. We are pleased to be overseeing the operation of such a crucial project and contributing to the development of the consensus document and scientific publication with the recommendations for HTA agencies."
Richard Charter Vice President MedTech Market Access - Europe & Asia Pacific at Alira Health

About Alira Health

Alira Health is an international patient-centric and technology-enabled advisory firm whose mission is to humanize healthcare. We work with healthcare and life sciences organizations looking for support across their entire solutions lifecycle. From development to medical care, we complement our clients’ expertise with a full spectrum of services including research and clinical development solutions, technology-powered consulting, and real-world evidence.

Our integrated and multidisciplinary team of over 500 scientists, strategists, economists, clinicians, and biostatisticians collaborate across our North American, European, and Asian offices and advise 80% of the top 50% of MedTech companies and 75% of the top 50% of Pharma companies.

About HTAi

Health Technology Assessment international (HTAi) is the global, non-profit, scientific, and professional society for all those who produce, use or encounter health technology assessment (HTA). The society represents 82 organizations and over 2,500 individual members from 65 countries around the world.

Related news

Webinars March 28, 2025
How Sustainability and Health Equity Are Reshaping Market Access Policy in Europe
This webinar will explore sustainability and health equity impact on reimbursement and procurement decisions in Europe and provide practical insights on how companies can adapt to the new landscape.
EU Market Access Sustainability
Articles March 6, 2025
ATMPs: Access, Pricing, and Ethical Issues in Perspective
Start reading this sneak peek of our recent analysis of access, pricing and ethical issues for advanced therapies medicinal products.
Advanced Therapies Market Access Orphan Drug Pricing
Articles February 17, 2025
Sustainable Pricing: An Opportunity to Improve Patient Access
Discover key pricing strategies to improve pharmaceutical health equity and price sustainability.
Market Access Pricing Sustainability
Articles January 24, 2025
How to Navigate the JCA Era: Market Access Strategy Optimization in the EU
With the JCA now in effect, we spoke with Andrea Mantovani, Alira Health Partner, Market Access and Pricing, about its impact on pharmaceutical companies hoping to bring new therapies to market.
EU Market Access
News January 8, 2025
Alira Health Launches the Global Payer Forum 2025 in Partnership with UPF Barcelona School of Management, NEWDIGS at Tufts Medical Center, and the University College of London
Alira Health is excited to announce the second year of the Global Payer Forum, a landmark educational initiative in partnership with distinguished academic institutions, UPF Barcelona(...)
Health Policy Market Access Pharma
Articles December 18, 2024
Market Access and Pricing Landscape for Diagnostic Radiopharmaceuticals
Discover the current market access and pricing landscape for diagnostic radiopharmaceuticals in key European markets, including the specific challenges, and discusses best practices(...)
Market Access Pricing Radiopharmaceuticals
Articles November 12, 2024
Funding and Procurement Trends in Radiopharmaceuticals
Discover how funding and procurement processes for commercial radiopharmaceuticals vary across Europe, including factors driving purchasing decisions.
Market Access Nuclear Medicine Radioligand Therapies (RLTs)
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.